First Trust Advisors LP Novavax Inc Transaction History

First Trust Advisors LP

$127 Billion
Q3 2025

A detailed history of First Trust Advisors LP transactions in Novavax Inc stock. As of the latest transaction made, First Trust Advisors LP holds 194,991 shares of NVAX stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

194,991

Previous 89,132 118.77%

Holding current value

$1.36 Million

Previous $561,000 201.25%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$6.56 - $9.71 $694,435 - $1.03 Million	105,859 Added 118.77%	194,991 $1.69 Million
Q2 2025 Aug 13, 2025	BUY	$5.43 - $7.74 $61,092 - $87,082	11,251 Added 14.45%	89,132 $561,000
Q1 2025 May 14, 2025	SELL	$6.41 - $10.82 $1.05 Million - $1.77 Million	-163,236 Reduced 67.7%	77,881 $499,000
Q4 2024 Feb 13, 2025	BUY	$7.22 - $14.68 $1.74 Million - $3.54 Million	241,117 New	241,117 $1.94 Million
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $3.52 Million - $7.62 Million	610,427 New	610,427 $4.23 Million
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $519,166 - $1.08 Million	-14,310 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $9.5 Million - $19.5 Million	-136,220 Reduced 90.49%	14,310 $1.05 Million
Q4 2021 Feb 08, 2022	SELL	$134.56 - $217.97 $18.9 Million - $30.7 Million	-140,621 Reduced 48.3%	150,530 $21.5 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $36.1 Million - $55 Million	203,135 Added 230.79%	291,151 $60.4 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $6.94 Million - $14.8 Million	57,354 Added 187.05%	88,016 $18.7 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $609,640 - $1.73 Million	-5,396 Reduced 14.96%	30,662 $5.56 Million
Q4 2020 Feb 02, 2021	BUY	$78.74 - $139.5 $2.84 Million - $5.03 Million	36,058 New	36,058 $4.02 Million

Others Institutions Holding NVAX

# of Institutions

309

Shares Held

95.6M

Call Options Held

5.7M

Put Options Held

9.06M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $545M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Novavax Inc Transaction History